SCHEDULE: Bank of America Reports 4% Stake in MacroGenics

Bank of America Corporation has disclosed a beneficial ownership of 4.0% in MacroGenics Inc., holding 2,556,475 shares.

Summary

• Bank of America Corporation, through its subsidiaries, now beneficially owns 2,556,475 shares of MacroGenics Inc. common stock.
• This represents 4.0% of the class of securities.
• The filing is an amendment to a previous Schedule 13G filing.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new financial or strategic information.

Positives

• Bank of America Corporation's filing indicates a significant institutional investor's presence, which can sometimes be viewed positively by the market.
• The ownership stake is reported as being held in the ordinary course of business, suggesting a standard investment rather than a hostile action.

Negatives

• The filing does not provide any new financial performance data or strategic updates for MacroGenics Inc., offering no insight into the company's operational health.
• The disclosure is a routine update on beneficial ownership, not an indicator of new investment conviction or a change in strategy by Bank of America.

Risks

• The filing does not explicitly mention any new risks for MacroGenics Inc. or its shareholders.
• However, any significant change in beneficial ownership, even if routine, can be interpreted by the market in various ways, potentially leading to short-term volatility.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains to beneficial ownership reporting.

Management Comments

• "The beneficial ownership calculation relies on the 63,563,123 outstanding shares disclosed in the Form 10-Q by the issuer on May 13, 2026, which reports share totals as of May 8, 2026."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for large financial institutions like Bank of America when their beneficial ownership of a public company's stock crosses certain reporting thresholds. This filing indicates a passive investment position rather than active control.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which may influence market perception but does not directly alter the company's operations or shareholder rights.
• Creditors: No direct impact is indicated.
• Employees: No direct impact is indicated.
• Suppliers: No direct impact is indicated.
• Customers: No direct impact is indicated.

Next Steps

• Bank of America Corporation will continue to report any changes in its beneficial ownership of MacroGenics Inc. stock as required by SEC regulations.

Key Dates

Keywords

beneficial ownership, Schedule 13G, institutional investor, common stock, investment holding, regulatory filing